10-Q Filing

SUPERNUS PHARMACEUTICALS, INC. CIK: 1356576 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001104659-14-079796`
Period End Date	20140930
Filing Date	20141112
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	supn-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 77 Cash Flow Statement 68 Comprehensive Income 16

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	39.98M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.93M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$49.21M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.93M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$34.78M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	39.98M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$15.30M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.05M	USD	Point-in-time
Interest receivable	`InterestReceivableCurrent`	$483.00K	USD	Point-in-time
Interest receivable	`InterestReceivableCurrent`	$493.00K	USD	Point-in-time
Inventories	`InventoryNet`	$7.15M	USD	Point-in-time
Inventories	`InventoryNet`	$11.14M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.05M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.30M	USD	Point-in-time
Deferred financing costs, current	`DeferredFinanceCostsCurrentNet`	$229.00K	USD	Point-in-time
Deferred financing costs, current	`DeferredFinanceCostsCurrentNet`	$166.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$102.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$97.16M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.55M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.13M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.16M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$8.76M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$15.76M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$360.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$361.00K	USD	Point-in-time
Deferred financing costs, long-term	`DeferredFinanceCostsNoncurrentNet`	$599.00K	USD	Point-in-time
Deferred financing costs, long-term	`DeferredFinanceCostsNoncurrentNet`	$1.00M	USD	Point-in-time
Total assets	`Assets`	$126.33M	USD	Point-in-time
Total assets	`Assets`	$111.00M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$21.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$18.31M	USD	Point-in-time
Deferred product revenue, net	`DeferredProductRevenueNetCurrent`	$7.88M	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$204.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.13M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.42M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.31M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$26.50M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$34.39M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.02M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.68M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$7.26M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$12.64M	USD	Point-in-time
Total liabilities	`Liabilities`	$77.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$60.21M	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at September 30, 2014 and December 31, 2013; 42,929,826 and 39,983,437 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at September 30, 2014 and December 31, 2013; 42,929,826 and 39,983,437 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$43.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$229.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$211.95M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-35.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-178.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-163.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$66.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$33.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$126.33M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$111.00M	USD	Point-in-time

Income Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net product sales	`SalesRevenueNet`	$59.06M	USD	3 Qtrs
Net product sales	`SalesRevenueNet`	$22.45M	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$1.28M	USD	3 Qtrs
Net product sales	`SalesRevenueNet`	$1.13M	USD	1 Quarter
Revenue from royalty agreement	`RevenueFromRoyaltyAgreement`	$30.00M	USD	3 Qtrs
Revenue from royalty agreement	`RevenueFromRoyaltyAgreement`	$30.00M	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$401.00K	USD	3 Qtrs
Licensing revenue	`LicensesRevenue`	$36.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$127.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$2.19M	USD	3 Qtrs
Total revenue	`Revenues`	$1.26M	USD	1 Quarter
Total revenue	`Revenues`	$1.68M	USD	3 Qtrs
Total revenue	`Revenues`	$91.24M	USD	3 Qtrs
Total revenue	`Revenues`	$52.49M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$37.00K	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$3.48M	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$33.00K	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$1.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.78M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$13.82M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$11.84M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$54.45M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.34M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$14.62M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$40.37M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$71.74M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$18.43M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$52.25M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$23.32M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$19.50M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$29.17M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-17.18M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-50.56M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$78.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$96.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$265.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$203.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$3.77M	USD	3 Qtrs
Interest expense	`InterestExpense`	$5.74M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.29M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.87M	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-12.69M	USD	3 Qtrs
Change in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$2.12M	USD	3 Qtrs
Change in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-4.15M	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$760.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-860.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.59M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.00K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$89.00K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$6.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-6.92M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-19.30M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-3.98M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-1.31M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-24.10M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$27.86M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-69.87M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$15.52M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-2.26	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.78	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.37	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.65	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-2.26	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.39	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.13	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.78	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.94M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.90M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.04M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.83M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.94M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.90M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.38M	shares	3 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-69.87M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$27.86M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$15.52M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-24.10M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-860.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.59M	USD	3 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$-12.69M	USD	3 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$2.12M	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$24.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$35.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$701.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$526.00K	USD	3 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.60M	USD	3 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$2.07M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$2.02M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.26M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.25M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$7.21M	USD	3 Qtrs
Interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	$10.00K	USD	3 Qtrs
Interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	$319.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.99M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.04M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.25M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$822.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.34M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.67M	USD	3 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$10.37M	USD	3 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$-7.88M	USD	3 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$869.00K	USD	3 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-168.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$465.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$337.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$739.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.53M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$78.97M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$34.57M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$41.99M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$47.67M	USD	3 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.41M	USD	3 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$475.00K	USD	3 Qtrs
Capitalized patent defense costs	`PaymentsToAcquireIntangibleAssets`	$306.00K	USD	3 Qtrs
Capitalized patent defense costs	`PaymentsToAcquireIntangibleAssets`	$3.15M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.80M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-33.02M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$265.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.16M	USD	3 Qtrs
Proceeds from convertible debt issuance	`ProceedsFromConvertibleDebt`	$90.00M	USD	3 Qtrs
Cash settlement of debt to equity conversion	`RepaymentsOfConvertibleDebt`	$1.00K	USD	3 Qtrs
Repayment of secured notes payable	`RepaymentsOfSecuredDebt`	$24.34M	USD	3 Qtrs
Financing costs and underwriters discounts	`PaymentsOfFinancingCosts`	$3.63M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$64.19M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$264.00K	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-17.36M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.80M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$22.95M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.95M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$975.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	$1.50M	USD	3 Qtrs
Conversion of convertible notes	`DebtConversionConvertedInstrumentAmount1`	$14.89M	USD	3 Qtrs
Initial value of interest make-whole derivative issued in connection with the convertible debt	`StockIssued1`	$9.27M	USD	3 Qtrs
Initial value of conversion option reported in equity	`DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent`	$22.34M	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-69.87M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$27.86M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$15.52M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-24.10M	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-35.00K	USD	3 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-24.00K	USD	3 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-36.00K	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$154.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00K	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-36.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-35.00K	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$154.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$15.48M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$27.82M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-23.94M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-69.89M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.